Antiemetic effect of propofol administered at the end of surgery in laparoscopic assisted vaginal hysterectomy

Eu-Gene Kim, Hye Jin Park, Hyoseok Kang, Juyoun Choi, Hyun Jeong Lee, Eu-Gene Kim, Hye Jin Park, Hyoseok Kang, Juyoun Choi, Hyun Jeong Lee

Abstract

Background: Postoperative nausea and vomiting (PONV) commonly occur after general anesthesia, especially in women. In this study, we evaluated the antiemetic efficacy of propofol administered at the end of surgery in highly susceptible patients undergoing a laparoscopy-assisted vaginal hysterectomy.

Methods: A total of 107 women undergoing a laparoscopy-assisted vaginal hysterectomy under general anesthesia were enrolled for this prospective, double-blind, randomized study. Fifteen minutes before the end of surgery, all patients received 50 µg fentanyl and 1 of following 3 doses; 0.5 mg/kg of propofol (propofol 0.5 group), 1 mg/kg of propofol (propofol 1.0 group), and normal saline (control group). All patients received intravenous patient-controlled analgesia (PCA). Emergence time, a visual analog scale for pain and nausea, duration of postanesthesia care unit (PACU) stay, and frequency of antiemetic use were recorded at 0-2, 2-24, and 24-48 hours postoperatively.

Results: The incidence of nausea significantly lower in the propofol 0.5 and propofol 1.0 groups than in the control group (12.1 vs 14.7 vs 40%). During the first postoperative 2 hours, antiemetics were less frequently administered in the propofol 0.5 and propofol 1.0 groups than in the control group (3.0 vs 5.9 vs 22.5%). Emergence time was slightly longer in the propofol 0.5 and propofol 1.0 groups than in the control group, but there was no significant difference in PACU stay time was observed between the 3 groups.

Conclusions: The results of this study suggest that low-dose propofol administration at the end of surgery may effectively reduce the incidence of PONV within 2 hours postoperatively in highly susceptible women undergoing a laparoscopiy-assisted vaginal hysterectomy and receiving opioid-based PCA.

Keywords: Laparoscopy; Opioid; Postoperative nausea and vomiting; Propofol.

Figures

Fig. 1
Fig. 1
The incidence of nausea and the number of rescue antiemetics are significantly lower in the propofol 0.5 and propofol 1.0 groups than in the control group during postoperative 2 hours. *P < 0.05 compared to the control group.

References

    1. Sinclair DR, Chung F, Mezei G. Can postoperative nausea and vomiting be predicted? Anesthesiology. 1999;91:109–118.
    1. Watcha MF, White PF. Postoperative nausea and vomiting. Its etiology, treatment and prevention. Anesthesiology. 1992;77:162–184.
    1. Borgeat A, Wilder-Smith OH, Wilder-Smith CH, Forni M, Suter PM. Propofol improves patient comfort during cisplatin chemotherapy. A pilot study. Oncology. 1993;50:456–459.
    1. Borgeat A, Wilder-Smith OH, Saiah M, Rifat K. Subhypnotic doses of propofol possess direct antiemetic properties. Anesth Analg. 1992;74:539–541.
    1. Erdem AF, Yoruk O, Alici HA, Cesur M, Atalay C, Altas E, et al. Subhypnotic propofol infusion plus dexamethasone is more effective dexamethasone alone for the prevention of vomiting in children after tonsillectomy. Paediatr Anaesth. 2008;18:878–883.
    1. Kim MS, Moon BE, Kim H, Lee JR. Comparison of propofol and fentanyl administered at the end of anaesthesia for prevention of emergence agitation after sevoflurane anaesthesia in children. Br J Anaesth. 2013;110:274–280.
    1. Aldrete JA. The post-anesthesia recovery score revisited. J Clin Anesth. 1995;7:89–91.
    1. Apfel CC, Läärä E, Koivuranta M, Greim CA, Roewer N. A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesiology. 1999;91:693–700.
    1. Kovac AL. Prevention and treatment of postoperative nausea and vomiting. Drugs. 2000;59:213–243.
    1. Koivuranta M, Läärä E, Ranta P, Ravaska P, Alahuhta S. Comparison of ondansetron and droperidol in the prevention of postoperative nausea and vomiting after laparoscopic surgery in women. A randomised, double-blind, placebo-controlled trial. Acta Anaesthesiol Scand. 1997;41:1273–1279.
    1. Smith I, White PF, Nathanson M, Gouldson R. Propofol. An update on its clinical use. Anesthesiology. 1994;81:1005–1043.
    1. Ostman PL, Faure E, Glosten B, Kemen M, Robert MK, Bedwell S. Is the antiemetic effect of the emulsion formulation of propofol due to the lipid emulsion? Anesth Analg. 1990;71:536–540.
    1. Hammas B, Hvarfner A, Thörn SE, Wattwill M. Effects of propofol on ipecacuanha induced nausea and vomiting. Acta Anaesthesiol Scand. 1998;42:447–451.
    1. Collins GG. Effects of the anesthetic 2,6-diisopropylphenol on synaptic transmission in the rat olfactory cortex slice. Br J Pharmacol. 1988;95:939–949.
    1. Schulman SR, Rockett CB, Canada AT, Glass PS. Long-term propofol infusion for refractory postoperative nausea: a case report with quantitative propofol analysis. Anesth Analg. 1995;80:636–637.
    1. Kim J, Jang GD, Kim DS, Min KT. Small dose of propofol combined with dexamethasone for postoperative vomiting in pediatric Moyamoya disease patients: a prospective, observer-blinded, randomized controlled study. Korean J Anesthesiol. 2013;64:127–132.
    1. Hughes MA, Glass PS, Jacobs JR. Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs. Anesthesiology. 1992;76:334–341.
    1. Yoo YC, Bai SJ, Lee KY, Shin S, Choi EK, Lee JW. Total intravenous anesthesia with propofol reduces postoperative nausea and vomiting in patients undergoing robot-assisted laparoscopic radical prostatectomy: a prospective randomized trial. Yonsei Med J. 2012;53:1197–1202.
    1. Pavlin DJ, Coda B, Shen DD, Tschanz J, Nguyen Q, Schaffer R, et al. Effects of combining propofol and alfentanil on ventilation, analgesia, sedation, and emesis in human volunteers. Anesthesiology. 1996;84:23–37.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi